JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 9, 2008; DOI: 10.1124/jpet.107.128215


0022-3565/08/3251-37-46$20.00
JPET 325:37-46, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.107.128215v1
325/1/37    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Télémaque, S.
Right arrow Articles by Marsh, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Télémaque, S.
Right arrow Articles by Marsh, J. D.

CARDIOVASCULAR

Design of Mutant β2 Subunits as Decoy Molecules to Reduce the Expression of Functional Ca2+ Channels in Cardiac CellsFormula

Sabine Télémaque, Swapnil Sonkusare, Terrie Grain, Sung W. Rhee, Joseph R. Stimers, Nancy J. Rusch, and James D. Marsh

Departments of Internal Medicine (S.T., T.G., J.D.M.) and Pharmacology and Toxicology (S.S., S.W.R., J.R.S., N.J.R.), College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Calcium influx through long-lasting ("L-type") Ca2+ channels (CaV) drives excitation-contraction in the normal heart. Dysregulation of this process contributes to Ca2+ overload, and interventions that reduce expression of the pore-forming {alpha}1 subunit may alleviate cytosolic Ca2+ excess. As a molecular approach to disrupt the assembly of CaV1.2 ({alpha}1C) channels at the cell membrane, we targeted the Ca2+ channel β2 subunit, an intracellular chaperone that interacts with {alpha}1C via its β interaction domain (BID) to promote CaV1.2 channel expression. Recombinant adenovirus expressing either the full β2 subunit (Full-β2) or truncated β2 subunit constructs lacking either the C terminus, N terminus, or both (N-BID, C-BID, and BID, respectively) fused to green fluorescent protein were developed as potential decoys and overexpressed in HL-1 cells. Fluorescence microscopy revealed that the localization of Full-β2 at the surface membrane was associated with increased Ca2+ current mainly attributed to CaV1.2 channels. In contrast, truncated N-BID and C-BID constructs showed punctate intracellular expression, and BID showed a diffuse cytosolic distribution. Total expression of the {alpha}1C protein of CaV1.2 channels was similar between groups, but HL-1 cells overexpressing C-BID and BID exhibited reduced Ca2+ current. C-BID and BID also attenuated Ca2+ current associated with another L-type Ca2+ channel, CaV1.3, but they did not reduce transient Ca2+ currents attributed to CaV3 channels. These results suggest that β2 subunit mutants lacking the N terminus may preferentially disrupt the proper localization of L-type Ca2+ channels in the cell membrane. Cardiac-specific delivery of these decoy molecules in vivo may represent a gene-based treatment for pathologies involving Ca2+ overload.


Address correspondence to: Dr. Sabine Télémaque, Division of Cardiovascular Medicine, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham, #832, Little Rock, AR 72205. E-mail: stelemaque{at}uams.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.